Caterina Sposetti: Excess weight and risk of 2nd primary tumors in early-stage cancer survivors
Caterina Sposetti, Medical Oncology Fellow, Dana-Farber Cancer Center, shared a post on X:
“New interesting article by Clara Bodelon et al. on JAMA Network Open about excess weight & risk of 2nd primary tumors in early-stage cancer survivors (n=26,894; mean age=72.2y at 1st diagnosis):
1/2 patient (42.8%) is overweight (BMI 25-29.9) and 1/5 (17.2%) obese (BMI≥30) at 1st diagnosis
Risk of obesity-related 2nd tumors (post-menopausal Breast, Colorectal, Kidney, Pancreatic): 40% for overweight (aHR, 1.40; 95% CI, 1.22,-1.61) & 78% for obese (aHR, 1.78; 95% CI, 1.51-2.11)
15% risk of any 2nd tumors in overweight (aHR 1.15; 95% CI, 1.07-1.25) and 34% risk in obese (aHR, 1.34; 95% CI, 1.21-1.48)
Essential to integrate healthy lifestyle recommendations for all patients in oncology practice!”
Authors: Clara Bodelon, et al.
Source: Caterina Sposetti/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023